With the rapid development of science and technology, the use of plastics in modern medicine is steadily increasing. Medical devices made from injection-molded plastics help reduce health care costs, infectious diseases and pain management. High-tech polymers are used in medical device prototyping and are often used to create improved prosthetics and devices to reduce the risk of infection. Medical plastic injection molding directly improves patient safety and the ability to save more lives. High-gloss injection molding: the basic process of high-gloss injection molding is to rapidly heat the surface of the mold with high temperature and high pressure steam before injection molding, so that the surface temperature of the molding mold cavity reaches above the glass transfer temperature (TG) of the resin plastic, and then inject the plasticized plastic melt into the closed mold cavity. During the injection phase, the mold temperature is kept constant by high temperature and high pressure steam. After injection molding, stop the air supply, blow out the steam in the tube with the air pressure of the duct, and then inject cooling water to make the mold temperature drop rapidly, until the mold is cooled and opened to take out the product. Custom Plastic Parts,Custom High Precision Plastic Injection Molding,Precision Plastic Injection Molding Accessories,Plastic Injection Molding Tooling Parts Suzhou Dongye Precision Molding Co.,Ltd. , https://www.sjdongye.com
The reason that caused the DNA sequencer market to suffer such heavy damage is related to the current application field of DNA sequencer. Due to the high price of the DNA sequencer, it is generally used in scientific research and the consumer groups are research institutions or researchers. In the context of the U.S. government’s cutbacks in research funding, many scientific research institutions have implemented delayed purchases and even no longer plan to purchase expensive instruments such as DNA sequencers. This has caused a great impact on the DNA sequencer market. The cruel reality is that not only research institutions in the future may be reluctant to purchase DNA sequencers. Because people expect that the government will continue to cut research funding in the future, the funding prospects are not optimistic, and scientific institutions naturally no longer plan to purchase expensive instruments such as DNA sequencer, leading to an entire market of DNA sequencers is not optimistic.
DNA sequencing market can only accept this cold stream, and can not turn it? Currently, DNA sequencer manufacturers are actively expanding new application areas to solve this problem. They set their sights on the biomedical field and placed their hopes on market prosperity here. They hope that the DNA sequencer can be used more in the field of clinical diagnosis of medicine to get out of this "cold stream" and welcome the warm current.
The DNA sequencer is used in the field of medical clinical diagnosis and can be mainly used for the screening of clinical genetic risk and the diagnosis of genetic diseases. Many companies also actively carry out other gene services, including genetic testing of individual cancer drugs. Will the DNA sequencer be able to pick up the DNA sequencer market from the scientific research field to the clinical medicine field? At least people in the industry are very optimistic. 
Reduced R&D Funds Decreased DNA Sequencer Market and Seek Warm Current in Medical Field
Although the discovery of DNA and the study of DNA sequencing are major breakthroughs in the course of human development, the current market development of DNA sequencers is experiencing a "cold stream." Since the beginning of this year, the market sales of DNA sequencers have continued to decline, and the downward trend will continue. This has also led to many manufacturers of DNA sequencers have to be forced to cut costs, pay cuts or layoffs.